244 related articles for article (PubMed ID: 20030258)
1. [Therapeutic strategy for familial amyloid polyneuropathy (FAP)].
Ikeda S
Rinsho Shinkeigaku; 2009 Nov; 49(11):953-5. PubMed ID: 20030258
[TBL] [Abstract][Full Text] [Related]
2. Diflunisal stabilizes familial amyloid polyneuropathy-associated transthyretin variant tetramers in serum against dissociation required for amyloidogenesis.
Tojo K; Sekijima Y; Kelly JW; Ikeda S
Neurosci Res; 2006 Dec; 56(4):441-9. PubMed ID: 17028027
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of familial amyloid polyneuropathy].
Adams D; Samuel D; Slama M
Presse Med; 2012 Sep; 41(9 Pt 1):793-806. PubMed ID: 22341949
[TBL] [Abstract][Full Text] [Related]
4. Steady turnover of amyloid fibril proteins in gastric mucosa after liver transplantation in familial amyloid polyneuropathy.
Tsuchiya-Suzuki A; Yazaki M; Sekijima Y; Kametani F; Ikeda S
Amyloid; 2013 Sep; 20(3):156-63. PubMed ID: 23826783
[TBL] [Abstract][Full Text] [Related]
5. Liver transplantation and new therapeutic approaches for familial amyloidotic polyneuropathy (FAP).
Ando Y
Med Mol Morphol; 2005 Sep; 38(3):142-54. PubMed ID: 16170462
[TBL] [Abstract][Full Text] [Related]
6. Familial amyloidotic polyneuropathy and transthyretin.
Nagasaka T
Subcell Biochem; 2012; 65():565-607. PubMed ID: 23225017
[TBL] [Abstract][Full Text] [Related]
7. Clinical picture and outcome of transthyretin-related familial amyloid polyneuropathy (FAP) in Japanese patients.
Ikeda S
Clin Chem Lab Med; 2002 Dec; 40(12):1257-61. PubMed ID: 12553427
[TBL] [Abstract][Full Text] [Related]
8. Recent progress in the understanding and treatment of transthyretin amyloidosis.
Sekijima Y
J Clin Pharm Ther; 2014 Jun; 39(3):225-33. PubMed ID: 24749898
[TBL] [Abstract][Full Text] [Related]
9. [Metabolic turn over of amyloid fibrils and post-treatment regression of amyloid deposits in systemic amyloidosis with polyneuropathy].
Ikeda S
Rinsho Shinkeigaku; 2011 Nov; 51(11):1143-5. PubMed ID: 22277512
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of diflunisal on autonomic dysfunction of late-onset familial amyloid polyneuropathy (TTR Val30Met) in a Japanese endemic area.
Takahashi R; Ono K; Shibata S; Nakamura K; Komatsu J; Ikeda Y; Ikeda T; Samuraki M; Sakai K; Iwasa K; Kayano D; Yamada M
J Neurol Sci; 2014 Oct; 345(1-2):231-5. PubMed ID: 25060417
[TBL] [Abstract][Full Text] [Related]
11. [Familial amyloid polyneuropathies: therapeutic issues].
Adams D; Cauquil C; Théaudin M
Bull Acad Natl Med; 2012 Oct; 196(7):1333-45; discussion 1345-7. PubMed ID: 23815018
[TBL] [Abstract][Full Text] [Related]
12. [The ocular involvement in the transthyretin-related familial amyloid polyneuropathy].
Lin HY; Dai RP
Zhonghua Yan Ke Za Zhi; 2017 Oct; 53(10):783-785. PubMed ID: 29050191
[TBL] [Abstract][Full Text] [Related]
13. Liver transplantation in transthyretin-related familial amyloid polyneuropathy.
Stangou AJ; Hawkins PN
Curr Opin Neurol; 2004 Oct; 17(5):615-20. PubMed ID: 15367866
[TBL] [Abstract][Full Text] [Related]
14. FAP neuropathy and emerging treatments.
Adams D; Théaudin M; Cauquil C; Algalarrondo V; Slama M
Curr Neurol Neurosci Rep; 2014 Mar; 14(3):435. PubMed ID: 24482069
[TBL] [Abstract][Full Text] [Related]
15. Finding of vascular amyloid TTR in inferior nasal concha in a patient with FAP TTRVal30Met.
Munar-Ques M; Martinez-Nadal J; Torres-Rovira JJ; Sole M; Zabay-Becerril JM; Mulet-Ferrer JM
Amyloid; 2008 Dec; 15(4):272-4. PubMed ID: 19065300
[TBL] [Abstract][Full Text] [Related]
16. A low amyloidogenic E61K transthyretin mutation may cause familial amyloid polyneuropathy.
Murakami T; Yokoyama T; Mizuguchi M; Toné S; Takaku S; Sango K; Nishimura H; Watabe K; Sunada Y
J Neurochem; 2021 Mar; 156(6):957-966. PubMed ID: 32852783
[TBL] [Abstract][Full Text] [Related]
17. [Effect of liver trasplantation on familial amyloidotic polyneuropathy (FAP) and its limt].
Ando Y
Rinsho Shinkeigaku; 2011 Nov; 51(11):1138-41. PubMed ID: 22277510
[TBL] [Abstract][Full Text] [Related]
18. Familial amyloid polyneuropathy.
Barreiros AP; Galle PR; Otto G
Dig Dis; 2013; 31(1):170-4. PubMed ID: 23797140
[TBL] [Abstract][Full Text] [Related]
19. Clinical and pathological findings in familial amyloid polyneuropathy caused by a transthyretin E61K mutation.
Murakami T; Nishimura H; Nagai T; Hemmi S; Kutoku Y; Ohsawa Y; Sunada Y
J Neurol Sci; 2017 Oct; 381():55-58. PubMed ID: 28991715
[TBL] [Abstract][Full Text] [Related]
20. Serum transthyretin monomer in patients with familial amyloid polyneuropathy.
Sekijima Y; Tokuda T; Kametani F; Tanaka K; Maruyama K; Ikeda S
Amyloid; 2001 Dec; 8(4):257-62. PubMed ID: 11791618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
